Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Transcatheter mitral valve implantation via transapical approach: an early experience†

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. 2019 EACTS Expert Consensus on long-term mechanical circulatory support

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Intraoperative flow profiles of arterial and venous bypass grafts to the left coronary territory

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Burden and causes for hospitalizations following coronary artery bypass grafting: a nationwide cohort study†

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Lung transplantation after ex vivo lung perfusion in two Scandinavian centres

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVES: As many as 50% of patients with severe symptomatic mitral valve regurgitation are denied surgical valve replacement or repair due to high operative risk. We describe an early series of cases of transcatheter implantation with a CardiAQ™ mitral valve via a transapical approach.

METHODS: Three consecutive patients with an Society of Thoracic Surgeons (STS) mortality score of >22% were selected for transcatheter mitral valve implantation (TMVI) on compassionate grounds. All patients were elderly, had severe mitral regurgitation (MR), were in Class IV heart failure and deemed unsuitable for the MitraClip. Two of the patients had functional MR in the setting of ischaemic cardiomyopathy with left ventricular ejection fraction (LVEF) <40%, deemed while the remaining patient had chordal rupture with extensive anterior leaflet flail (preserved LVEF). Comorbidities included previous coronary artery bypass surgery (n = 2), severe pulmonary hypertension (n = 1) and moderate to severe chronic renal failure (n = 3). A CardiAQ mitral valve was implanted using fluoroscopy and transoesophageal (TEE) guidance via a standard transapical approach.

RESULTS: Accurate prosthesis positioning and deployment with immediate elimination of the MR was achieved in all 3 cases. Two patients made full clinical recovery and were discharged home. Post-procedural TEE performed on Days 1, 30 and 60 days showed good valve function, stable valve position and minimal LVOT gradient. One patient expired on the postoperative day 9 due to pneumonia.

CONCLUSIONS: TMVI using the CardiAQ™ device via a transapical approach is feasible and effective.

Original languageEnglish
JournalEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
Volume48
Issue number6
Pages (from-to)873-8
Number of pages6
ISSN1010-7940
DOIs
Publication statusPublished - Dec 2015

ID: 46182165